Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals

BACKGROUND: This study aimed at evaluation and comparison of PastoCovac Plus protein-subunit vaccine in parallel with ChAdOx1-S (AstraZeneca) and BBIBP-CorV (Sinopharm) in primarily vaccinated volunteers with two doses of ChAdOx1-S or BBIBP-CorV. MATERIALS AND METHODS: 194 volunteers enrolled the st...

Descripción completa

Detalles Bibliográficos
Autores principales: Eybpoosh, Sana, Biglari, Alireza, Sorouri, Rahim, Ashrafian, Fatemeh, Sadat Larijani, Mona, Verez-Bencomo, Vicente, Toledo-Romani, Maria Eugenia, Valenzuela Silva, Carmen, Salehi-Vaziri, Mostafa, Dahmardeh, Sarah, Doroud, Delaram, Banifazl, Mohammad, Mostafavi, Ehsan, Bavand, Anahita, Ramezani, Amitis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619776/
https://www.ncbi.nlm.nih.gov/pubmed/37910480
http://dx.doi.org/10.1371/journal.ppat.1011744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619776/
https://www.ncbi.nlm.nih.gov/pubmed/37910480
http://dx.doi.org/10.1371/journal.ppat.1011744

Ejemplares similares